Imaging News and Research

RSS

Stroke patients report improvements in their motor function using novel rehabilitation device

Using a novel stroke rehabilitation device that converts an individual's thoughts to electrical impulses to move upper extremities, stroke patients reported improvements in their motor function and ability to perform activities of daily living. Results of the study were presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

MRI provides noninvasive way to measure iron levels in the brains of ADHD people

Magnetic resonance imaging provides a noninvasive way to measure iron levels in the brains of people with attention deficit hyperactivity disorder, according to a study being presented today at the annual meeting of the Radiological Society of North America. Researchers said the method could help physicians and parents make better informed decisions about medication.

2 Dec 2013

Soldiers who suffer blast-induced MTBI exhibit long-term brain differences

Using a special type of magnetic resonance imaging, researchers have found that soldiers who suffered mild traumatic brain injury induced by blast exposure exhibit long-term brain differences, according to a study being presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

Study reveals effect of energy drinks on the function of the heart

Healthy adults who consumed energy drinks high in caffeine and taurine had significantly increased heart contraction rates one hour later, according to a study presented today at the annual meeting of the Radiological Society of North America.

2 Dec 2013

World-class Krembil Discovery Tower now opens in Canada

The Honourable Dr. K. Kellie Leitch, Minister of Labour and Minister of Status of Women congratulated Toronto Western Hospital today on the opening of the Krembil Discovery Tower, a facility dedicated to research excellence, training the next generation of medical professionals and improving health care for patients across Canada.

2 Dec 2013

NDSC offers free trial access to ACR Select portal

National Decision Support Company, the American College of Radiology's partner for the distribution of the ACR Appropriateness Criteria is offering free trial access to its ACR Select portal.

1 Dec 2013

Royal Philips showcases EPIQ and AlluraClarity systems at RSNA 2013

Today, at the 99th Annual Meeting of the Radiological Society of North America in Chicago, Royal Philips showcases its EPIQ premium ultrasound system that combines an exceptional level of clinical performance, advanced system intelligence and intuitive design, and its AlluraClarity interventional X-ray system that provides high quality imaging for a comprehensive range of clinical procedures, achieving excellent visibility at low X-ray dose levels for patients of all sizes.

From Philips Healthcare 1 Dec 2013

CoActiv Medical to introduce EXAM-PACS version 3.0 at 2013 RSNA conference

CoActiv Medical debuts at the 2013 Radiological Society of North America conference EXAM-PACS version 3.0. CoActiv leverages its longstanding experience with standards-based technology to bring new market-leading features and functionality to its flagship enterprise PACS and to provide more options and flexibility across the entire product line with expanded deployment options and a more robust vendor neutral archive.

29 Nov 2013

Study brings effective hepatitis C cure closer to reality

Scientists at The Scripps Research Institute have determined the most detailed picture yet of a crucial part of the hepatitis C virus, which the virus uses to infect liver cells. The new data reveal unexpected structural features of this protein and should greatly speed efforts to make an effective hepatitis C vaccine.

29 Nov 2013

Smartphone-based imaging could help physicians in remote locations to monitor patients' health

The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series features an advance in smartphone-based imaging that could help physicians in resource-limited locations monitor their patients' health.

28 Nov 2013

Leti highlights new imaging technology at IEEE Nuclear Science Symposium & Medical Imaging Conference

Researchers from CEA-Leti’s Detector Laboratory presented four oral papers and one invited paper at the recent IEEE Nuclear Science Symposium & Medical Imaging Conference & Workshop on Room-Temperature Semiconductor X-Ray and Gamma-Ray Detectors in Seoul, Korea.

28 Nov 2013

NIBIB-funded researchers explore better treatment for brain aneurysms

Thirty thousand Americans suffer severe neurological damage or death from brain aneurysms each year and the existing treatments eventually fail in nearly half of patients. Currently, these "bubbles" in the blood vessel are either clamped off, which requires invasive brain surgery, or filled with platinum coils to induce clotting in the aneurysm. Both treatments, although somewhat effective, can have subsequent problems, including inflammation, incomplete healing, and the development of secondary aneurysms adjacent to the initial site. These complications result in approximately 40 percent of patients needing additional treatment to attempt to re-repair the aneurysm.

28 Nov 2013

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer

Drugs delivered by nanoparticles hold promise for targeted treatment of many diseases, including cancer. However, the particles have to be injected into patients, which has limited their usefulness so far.

27 Nov 2013

Findings highlight possible new approach to combat malaria

An international team of scientists, including researchers at Columbia University Medical Center, has identified a key metabolic enzyme that common malaria parasites require for survival at each stage of infection in humans. The findings raise the possibility of a new approach to combating malaria, one of the world's deadliest diseases. The study was published today in the online edition of the journal Nature.

27 Nov 2013

Neuroimaging could predict psychosis treatment response

Assessing white matter integrity in patients with first-episode psychosis may predict who will respond to antipsychotic treatment, research suggests.

27 Nov 2013

RSNA and Regenstrief Institute partner to standardize radiology procedure names

Under a contract awarded by the National Institute of Biomedical Imaging and Bioengineering, the developers of two advanced medical terminologies have begun work to harmonize and unify terms for radiology procedures. Creating standardized radiology procedure names will improve the quality, consistency and interoperability of radiology test results in electronic medical record systems and health information exchange.

27 Nov 2013

Preterm infants at high risk for significant long-term problems

Premature birth appears to trigger developmental processes in the white matter of the brain that could put children at higher risk of problems later in life, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).

27 Nov 2013

Bioaxial secures funds to market optical microscopy modules

Bioaxial, developers of super-resolved fluorescence microscopy for the extended imaging of live cells, today announces the completion of a EUR 1.9 million (USD 2.7 million) equity investment by three new large investors; Amorcage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and Viveris Management plus a range of individual investors.

27 Nov 2013

SMART Medical Systems, PENTAX Medical announce strategic pan-European alliance

SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, and PENTAX Medical, an industry leader in endoscopic imaging, announced a strategic pan-European alliance, under which PENTAX Medical will commercialize SMART's novel G-EYE™ endoscope in Europe, the Middle-East and Africa (EMEA)

27 Nov 2013

FDA grants Orphan Drug Designation to CMC Contrast's CMC-001 MRI contrast media

CMC Contrast AB, a privately owned drug development company that is developing a targeted contrast agent for Magnetic Resonance Imaging (MRI), announced today that Orphan Drug Designation has been granted by the US Food and Drug Administration (FDA) for its liver specific contrast agent CMC-001.

27 Nov 2013